Liquid biopsy rapid temperature detection rookie to help you!

As a branch of in vitro diagnostics, a liquid biopsy is a non-invasive blood test that monitors the release of circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA) fragments from tumors or metastases into the bloodstream. The breakthrough technology of adjuvant therapy has gradually entered the clinical stage. The latest development in China is the approval of the CTC kit for lung cancer by the Drug Administration Bureau to drive the industry into application.

The advantage of liquid biopsy is that it can solve the pain points of precision medical treatment , reduce the risk of biopsy through non-invasive sampling, and effectively prolong the survival of patients, which is cost-effective. Liquid biopsy techniques mainly include CTC and ctDNA, as well as exosome detection.

Let us take a look at the industry dynamics and research progress on liquid biopsy.

1. Liquid biopsy - a reliable guarantee for curing cancer

Recently, the leading research team of the Dana Farber Cancer Institute of Harvard Medical School successfully confirmed the feasibility of a simple liquid biopsy technique as a clinical tool to identify specific patients. According to their report, this simple liquid biopsy technique quickly and accurately detects two key gene-causing mutations that cause non-small cell lung cancer (NSCLC), which in turn helps clinicians develop chemotherapeutic drugs for these two mutations. To improve the clinical treatment level of non-small cell lung cancer. "We believe that plasma genotyping has immeasurable potential for clinical testing. This rapid and non-invasive screening of conventional genetic imprinting of cancers can avoid the challenge of traditional invasive biopsy." The first author of the article, Dr. Geoffrey Oxnard, a lung cancer specialist at Dana Farber/Bregan Women's Hospital, said. (Original: Prospective Validation of Rapid Plasma Genotyping for the Detection of EGFR and KRAS Mutations in Advanced Lung Cancer)

2.Nature Supplement: New Progress in Liquid Biopsy Technology

High-throughput sequencing of circulating tumor DNA (ctDNA) is expected to achieve personalized cancer treatment. However, the free DNA (cfDNA) in the blood is limited, limiting the sensitivity of the assay. To this end, researchers at Stanford University have recently developed an error correction method that detects mutant alleles with frequencies as low as 0.004%. In Nature Biotechnology, published on March 28th, the researchers introduced this approach called Integrated Digital Error Suppression (IDES). It is based on a ctDNA detection technology previously developed by the Stanford team, called CAPP-seq, which has been acquired by Roche. (Original digital error suppression for improved detection of circulating tumor DNA)

Small 2D LiDAR Sensor

IT02S, is JRT new product in the early 2019, which is a single-point LiDAR sensor, also called tof distance sensor. With a micro size of 46x17x7mm, customers can widely use in many Laser Measurement Solutions. The lidar distance sensor can measure 12m short-range with high frequency up to 100hz. It's great for Unmanned Aerial Systems. If you need us send you data sheet and spec for this products, offering sample as well, pls tell us, thank you.

IT02S Mini Tof Sensor Module Diagram

Parameters of IT02S:

2D Laser Distance Sensor,2D Lidar Sensors,Tof Lidar Distance Sensor, Flight Distance Sensor

Chengdu JRT Meter Technology Co., Ltd , https://www.rangingsensor.com